Denso and Global Mobility Service (GMS) are to support the delivery of polymerase chain reaction (PCR) testing kits, which detect COVID-19 and the raw materials for the kits to medical institutions, testing organisations and pharmaceutical companies in Indonesia.
Health care workers in Indonesia have relied on imported PCR test kits to trace and fight the virus, but growing demand has caused a shortage of the critical tests.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Led by the Indonesian Agency for Technology Evaluation and Application (Badan Pengkajian dan Penerapan Teknologi), a project was launched to mass produce 100,000 PCR testing kits in Indonesia.
Denso and GMS have joined Indonesian companies in supporting the project. To that end, Bio Farma, an Indonesian State-run pharmaceutical company, has already started mass production of PCR test kits.
Delivery of PCR testing kits and their raw materials requires maintenance of a strict low-temperature transport environment of -20°C or lower, adherence to hygiene standards and real-time tracking of vehicle locations.
Since 5 May, Denso and GMS have provided small refrigerated trucks to help the effort. The trucks’ original purpose was for a demonstration project for small refrigerated transport services launched in Indonesia in October, 2019.
The companies plan to continue supporting the distribution of PCR testing kits to medical institutions and testing institutions in Jakarta and surrounding areas.
